Saint Paul, MN, United States of America

John M Heapy

This inventor holds 1 USPTO granted patent. Top assignee: 3M Innovative Properties Company. Active years: 2016.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John M Heapy: Innovator in Antimicrobial Compositions

Introduction

John M Heapy is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of antimicrobial compositions, showcasing his expertise and innovative spirit. His work is particularly relevant in today's context, where the demand for effective antimicrobial solutions is ever-increasing.

Latest Patents

Heapy holds a patent for a "Hardenable antimicrobial composition." This patent describes antimicrobial compositions that include a polyhaloolefin polymer, a cationic antimicrobial agent, and a vehicle that consists of a plasticizer and a heat stabilizer. The cationic antimicrobial agent can be partially soluble in the vehicle, which enhances its effectiveness. The patent also covers articles formed from the composition, with the cationic antimicrobial agent incorporated throughout the polymer matrix, as well as methods of manufacturing the composition. He has 1 patent to his name.

Career Highlights

John M Heapy is associated with 3M Innovative Properties Company, where he has been instrumental in developing innovative solutions. His work at 3M reflects a commitment to advancing technology and improving product efficacy in various applications.

Collaborations

Heapy has collaborated with notable colleagues, including Ranjani V Parthasarathy and Vinod P Menon. These collaborations have likely contributed to the success of his projects and the development of new technologies.

Conclusion

John M Heapy's contributions to antimicrobial compositions highlight his role as an innovator in the field. His patent work and collaborations demonstrate a commitment to advancing technology and addressing critical needs in antimicrobial solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…